Swiss Life Sciences Trend Analysis 2014

While the number of Swiss Biotech companies in 2013 remained close to its 2012 levels, the total financing value amassed within the sector more than doubled compared to last year’s figure, reaching USD 325m (112% increase).

Click here to download Swiss Life Sciences Trend Analysis 2014 – 14 pages

Looking for your next Biotech or Medtech partner?

Use Biotechgate to identify new leads, licensing opportunities and management details.